Clinical trials
Heart Diseases trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Recruiting | 7 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 3 |
| Biotronik SE & Co. KG | 3 |
| Eli Lilly and Company | 3 |
| Boston Scientific Corporation | 2 |
| Cardurion Pharmaceuticals, Inc. | 2 |
| GlaxoSmithKline | 2 |
| OrbusNeich | 2 |
| Weill Medical College of Cornell University | 2 |
| Abcentra | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Diseases | 37 |
| Cardiovascular Diseases | 21 |
| Heart Failure | 11 |
| Coronary Artery Disease | 7 |
| Myocardial Infarction | 6 |
| Stroke | 6 |
| Acute Coronary Syndrome | 5 |
| Atrial Fibrillation | 5 |
| Cardiomyopathies | 5 |
| Arrhythmias, Cardiac | 4 |
Trials
Showing 76 to 37 of 37. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.